University of Connecticut Health Center
Farmington, Connecticut, 06030-5215, United States
NCT Number: NCT00664053
The purpose of this study is to examine whether muscle strength and balance will improve in women with frailty selected for dehydroepiandrosterone sulfate (DHEAS) levels below 550 ng/dl treated with DHEAS supplementation and Hatha yoga. Investigators believe the effects of both treatments will improve outcomes more than either treatment alone and may be additive; in addition, lean body mass, skeletal muscle mass, markers of bone turnover and physical performance will improve following treatment with DHEA and/or yoga.
Looking for future studies?
Notify Me65 year and older
Female
Interventional
Phase 4
Farmington, Connecticut, 06030-5215, United States
Dehydroepiandrosterone (DHEAS) and yoga may mitigate or reverse the effects of aging and frailty on bone, muscle and balance loss. The mechanism of the effects may be direct - working through androgen or estrogen receptors in bone, muscle or brain. Or the effects may be indirect, countering effects of the stress response.
The specific aims of this study are:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
50mg daily for 6 months
Other names: Dehydroepiandrosterone
2 sessions per week for 6 months
Placebo supplement every day for 6 months
Walking/chair aerobics program 2 sessions per week for 6 months
Time frame: baseline, 3 month and 6 months
Time frame: baseline and 6 months
Time frame: baseline and 6 months
National Aeronautics and Space Administration (NASA)
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05445336
Bone Diseases, Bone Diseases, Metabolic
Hamilton, Ontario, Canada
View Trial DetailsNCT04663685
Arthritis, Behavior
Waterloo, Canada
View Trial DetailsNCT00718432
Behavior, Behavioral Symptoms
Zhunan, Taiwan
View Trial DetailsNCT00182871
Aging, Bone Diseases
Farmington, Connecticut, United States
View Trial Details